Borrower record · Q2 2026
Alcresta Therapeutics
As filed by 4 BDCs · period end 30 June 2026NAICS 31-33 · Manufacturing1 name variant under review
Four lenders report $50.3m of Alcresta Therapeutics at Q2 2026, marked at par. First-Lien Senior Secured on all nine positions whose seniority a filer disclosed.
- Filed fair value
- $50.3m
- 9 funded positions
- Reporting lenders
- 4
- across 9 filed positions
- Aggregate mark
- 100.5c
- cost filed on all 9 positions
- Median spread
- 525bp
- over SOFR, 9 tranches
- Maturities to
- 2031
- earliest March 2031
- Periods on record
- 5
- Q4 2025 → Q2 2026
How this total is counted
- Every figure above is the sum of 9 funded positions filed by 4 BDCs, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
- 1 filed name variant is under review against this borrower. Until it is resolved, anything filed under that name is counted nowhere on this page.
Pricing as filed
9 floating tranches · SOFR525bp on all 9 floating tranches — every filer reports the same spread.
4 tranches carry an index floor of 1%.
Capital structure
First-Lien Senior Secured, on all 9 positions whose seniority a filer disclosed.
Rate structure
Floating, on all 9 positions whose interest type a filer disclosed.
Maturity profile
all 9 funded positions dated4.7 years to maturity, weighted by fair value across the 9 dated positions.
Where the lenders disagree
4 filers disclosed a costLender marks on the same debt differ by up to 1.5c.
Filed over time
3 periods · aggregate onlyFiled fair value
Aggregate marknot to zero
Q4 2025, Q1 2026, Q2 2026 — every filer reporting the borrower at each period, aggregated. No lender is separated out at any period.
Credit flags
No lender reports this borrower on non-accrual, and no filed tranche pays in kind.
Not in the filings
- Q2 2025 and Q3 2025 are on record but not drawn: a different set of lenders reported them, so the totals are not comparable with the rest.
- Sector rests on 2 filers' labels; 2 of the 4 lenders filed none.
Sign up for free
Who holds it, and where they mark it.
4 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.
- The spread between the highest and lowest lender mark
- Quarter-on-quarter movement across 5 periods
- Peer comparison against borrowers with the same lenders
- The 10-Q or 10-K behind every row, by accession number
Every filing behind this page
4 filers · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Apollo Debt Solutions BDC (ADS) | 0001837532 | 10-Q | 2026-06-30 | 2026-08-10 | 0001193125-26-341358 |
| Ares Capital Corporation (ARCC) | 0001287750 | 10-Q | 2026-06-30 | 2026-07-29 | 0001628280-26-050307 |
| Ares Strategic Income Fund (ASIF) | 0001918712 | 10-Q | 2026-06-30 | 2026-08-07 | 0001628280-26-054923 |
| MidCap Financial Investment Corp (MFIC) | 0001278752 | 10-Q | 2026-06-30 | 2026-08-06 | 0001193125-26-335848 |
Related borrowers
Same lenders
Same sector